nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—osteoarthritis—Prednisone—ulcerative colitis	0.158	0.5	CpDpCtD
Sulindac—osteoarthritis—Methylprednisolone—ulcerative colitis	0.158	0.5	CpDpCtD
Sulindac—PTGS1—ulcerative colitis	0.123	0.481	CbGaD
Sulindac—PTGS2—ulcerative colitis	0.0706	0.275	CbGaD
Sulindac—ALB—ulcerative colitis	0.0629	0.245	CbGaD
Sulindac—PTGS2—Olsalazine—ulcerative colitis	0.0367	0.127	CbGbCtD
Sulindac—PTGS2—Balsalazide—ulcerative colitis	0.0327	0.113	CbGbCtD
Sulindac—PTGS1—Olsalazine—ulcerative colitis	0.031	0.107	CbGbCtD
Sulindac—PTGS1—Balsalazide—ulcerative colitis	0.0276	0.0958	CbGbCtD
Sulindac—PTGS2—Mesalazine—ulcerative colitis	0.0261	0.0907	CbGbCtD
Sulindac—PTGS1—Mesalazine—ulcerative colitis	0.0221	0.0766	CbGbCtD
Sulindac—CYP1A1—Nicotine—ulcerative colitis	0.0159	0.055	CbGbCtD
Sulindac—PTGS2—Sulfasalazine—ulcerative colitis	0.0146	0.0507	CbGbCtD
Sulindac—PTGS2—Triamcinolone—ulcerative colitis	0.0146	0.0507	CbGbCtD
Sulindac—CYP1A1—Cholecalciferol—ulcerative colitis	0.0142	0.0494	CbGbCtD
Sulindac—PTGS2—Betamethasone—ulcerative colitis	0.0125	0.0435	CbGbCtD
Sulindac—PTGS1—Sulfasalazine—ulcerative colitis	0.0123	0.0428	CbGbCtD
Sulindac—ALB—Prednisone—ulcerative colitis	0.00736	0.0255	CbGbCtD
Sulindac—PTGS2—Dexamethasone—ulcerative colitis	0.00729	0.0253	CbGbCtD
Sulindac—CYP1A2—Nicotine—ulcerative colitis	0.00708	0.0246	CbGbCtD
Sulindac—CYP1A1—Dexamethasone—ulcerative colitis	0.00615	0.0214	CbGbCtD
Sulindac—AKR1B1—epithelium—ulcerative colitis	0.00128	0.0911	CbGeAlD
Sulindac—AKR1B1—smooth muscle tissue—ulcerative colitis	0.00123	0.0878	CbGeAlD
Sulindac—AKR1B1—lymphoid tissue—ulcerative colitis	0.000986	0.0702	CbGeAlD
Sulindac—AKR1B1—digestive system—ulcerative colitis	0.000974	0.0693	CbGeAlD
Sulindac—MAPK3—epithelium—ulcerative colitis	0.000928	0.066	CbGeAlD
Sulindac—MAPK3—smooth muscle tissue—ulcerative colitis	0.000894	0.0636	CbGeAlD
Sulindac—PPARD—lymphoid tissue—ulcerative colitis	0.000775	0.0552	CbGeAlD
Sulindac—PPARD—digestive system—ulcerative colitis	0.000766	0.0545	CbGeAlD
Sulindac—AKR1B1—liver—ulcerative colitis	0.000726	0.0516	CbGeAlD
Sulindac—MAPK3—lymphoid tissue—ulcerative colitis	0.000715	0.0509	CbGeAlD
Sulindac—MAPK3—digestive system—ulcerative colitis	0.000706	0.0502	CbGeAlD
Sulindac—PPARD—liver—ulcerative colitis	0.000571	0.0406	CbGeAlD
Sulindac—MAPK3—liver—ulcerative colitis	0.000526	0.0374	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000371	0.247	CbGdCrCtD
Sulindac—CYP1A1—epithelium—ulcerative colitis	0.000287	0.0204	CbGeAlD
Sulindac—PTGS1—epithelium—ulcerative colitis	0.000252	0.0179	CbGeAlD
Sulindac—ALB—liver—ulcerative colitis	0.000251	0.0179	CbGeAlD
Sulindac—PTGS1—smooth muscle tissue—ulcerative colitis	0.000243	0.0173	CbGeAlD
Sulindac—PTGS2—epithelium—ulcerative colitis	0.000241	0.0172	CbGeAlD
Sulindac—PTGS2—smooth muscle tissue—ulcerative colitis	0.000232	0.0165	CbGeAlD
Sulindac—CYP1A2—digestive system—ulcerative colitis	0.000221	0.0158	CbGeAlD
Sulindac—CYP1A1—digestive system—ulcerative colitis	0.000218	0.0155	CbGeAlD
Sulindac—PTGS1—digestive system—ulcerative colitis	0.000192	0.0137	CbGeAlD
Sulindac—PTGS2—lymphoid tissue—ulcerative colitis	0.000186	0.0132	CbGeAlD
Sulindac—PTGS2—digestive system—ulcerative colitis	0.000183	0.0131	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000179	0.119	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000176	0.118	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000176	0.118	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000172	0.115	CbGdCrCtD
Sulindac—CYP1A2—liver—ulcerative colitis	0.000165	0.0117	CbGeAlD
Sulindac—CYP1A1—liver—ulcerative colitis	0.000163	0.0116	CbGeAlD
Sulindac—PTGS2—liver—ulcerative colitis	0.000137	0.00972	CbGeAlD
Sulindac—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000108	0.0721	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000106	0.0709	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000106	0.0709	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.000104	0.0693	CbGdCrCtD
Sulindac—Ill-defined disorder—Methylprednisolone—ulcerative colitis	5.82e-05	0.00101	CcSEcCtD
Sulindac—Alopecia—Dexamethasone—ulcerative colitis	5.79e-05	0.001	CcSEcCtD
Sulindac—Alopecia—Betamethasone—ulcerative colitis	5.79e-05	0.001	CcSEcCtD
Sulindac—Convulsion—Hydrocortisone—ulcerative colitis	5.79e-05	0.001	CcSEcCtD
Sulindac—Hypertension—Hydrocortisone—ulcerative colitis	5.76e-05	0.001	CcSEcCtD
Sulindac—Diarrhoea—Azathioprine—ulcerative colitis	5.76e-05	0.000998	CcSEcCtD
Sulindac—Discomfort—Prednisolone—ulcerative colitis	5.75e-05	0.000997	CcSEcCtD
Sulindac—Angioedema—Triamcinolone—ulcerative colitis	5.74e-05	0.000996	CcSEcCtD
Sulindac—Angioedema—Methylprednisolone—ulcerative colitis	5.73e-05	0.000994	CcSEcCtD
Sulindac—Myalgia—Hydrocortisone—ulcerative colitis	5.68e-05	0.000986	CcSEcCtD
Sulindac—Malaise—Triamcinolone—ulcerative colitis	5.67e-05	0.000983	CcSEcCtD
Sulindac—Malaise—Methylprednisolone—ulcerative colitis	5.66e-05	0.000981	CcSEcCtD
Sulindac—Vertigo—Triamcinolone—ulcerative colitis	5.65e-05	0.000979	CcSEcCtD
Sulindac—Hypersensitivity—Mesalazine—ulcerative colitis	5.65e-05	0.000979	CcSEcCtD
Sulindac—Syncope—Triamcinolone—ulcerative colitis	5.64e-05	0.000978	CcSEcCtD
Sulindac—Vertigo—Methylprednisolone—ulcerative colitis	5.64e-05	0.000977	CcSEcCtD
Sulindac—Syncope—Methylprednisolone—ulcerative colitis	5.63e-05	0.000975	CcSEcCtD
Sulindac—Discomfort—Hydrocortisone—ulcerative colitis	5.62e-05	0.000974	CcSEcCtD
Sulindac—Nausea—Budesonide—ulcerative colitis	5.6e-05	0.00097	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisolone—ulcerative colitis	5.58e-05	0.000967	CcSEcCtD
Sulindac—Oedema—Prednisolone—ulcerative colitis	5.58e-05	0.000967	CcSEcCtD
Sulindac—Dizziness—Azathioprine—ulcerative colitis	5.56e-05	0.000965	CcSEcCtD
Sulindac—Loss of consciousness—Triamcinolone—ulcerative colitis	5.53e-05	0.000958	CcSEcCtD
Sulindac—Loss of consciousness—Methylprednisolone—ulcerative colitis	5.51e-05	0.000956	CcSEcCtD
Sulindac—Asthenia—Mesalazine—ulcerative colitis	5.5e-05	0.000953	CcSEcCtD
Sulindac—Shock—Prednisolone—ulcerative colitis	5.49e-05	0.000952	CcSEcCtD
Sulindac—Oedema—Hydrocortisone—ulcerative colitis	5.45e-05	0.000945	CcSEcCtD
Sulindac—Anaphylactic shock—Hydrocortisone—ulcerative colitis	5.45e-05	0.000945	CcSEcCtD
Sulindac—Convulsion—Triamcinolone—ulcerative colitis	5.45e-05	0.000944	CcSEcCtD
Sulindac—Tachycardia—Prednisolone—ulcerative colitis	5.45e-05	0.000944	CcSEcCtD
Sulindac—Convulsion—Methylprednisolone—ulcerative colitis	5.44e-05	0.000942	CcSEcCtD
Sulindac—Hypertension—Triamcinolone—ulcerative colitis	5.43e-05	0.000941	CcSEcCtD
Sulindac—Pruritus—Mesalazine—ulcerative colitis	5.42e-05	0.00094	CcSEcCtD
Sulindac—Hypertension—Methylprednisolone—ulcerative colitis	5.42e-05	0.000939	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisolone—ulcerative colitis	5.39e-05	0.000935	CcSEcCtD
Sulindac—Shock—Hydrocortisone—ulcerative colitis	5.36e-05	0.00093	CcSEcCtD
Sulindac—Myalgia—Triamcinolone—ulcerative colitis	5.35e-05	0.000928	CcSEcCtD
Sulindac—Vomiting—Azathioprine—ulcerative colitis	5.35e-05	0.000927	CcSEcCtD
Sulindac—Myalgia—Methylprednisolone—ulcerative colitis	5.34e-05	0.000926	CcSEcCtD
Sulindac—Arthralgia—Methylprednisolone—ulcerative colitis	5.34e-05	0.000926	CcSEcCtD
Sulindac—Tachycardia—Hydrocortisone—ulcerative colitis	5.32e-05	0.000922	CcSEcCtD
Sulindac—Rash—Azathioprine—ulcerative colitis	5.3e-05	0.00092	CcSEcCtD
Sulindac—Dermatitis—Azathioprine—ulcerative colitis	5.3e-05	0.000919	CcSEcCtD
Sulindac—Flushing—Prednisone—ulcerative colitis	5.3e-05	0.000918	CcSEcCtD
Sulindac—Ill-defined disorder—Dexamethasone—ulcerative colitis	5.29e-05	0.000918	CcSEcCtD
Sulindac—Ill-defined disorder—Betamethasone—ulcerative colitis	5.29e-05	0.000918	CcSEcCtD
Sulindac—Discomfort—Triamcinolone—ulcerative colitis	5.29e-05	0.000917	CcSEcCtD
Sulindac—Discomfort—Methylprednisolone—ulcerative colitis	5.28e-05	0.000915	CcSEcCtD
Sulindac—Headache—Azathioprine—ulcerative colitis	5.27e-05	0.000914	CcSEcCtD
Sulindac—Hyperhidrosis—Hydrocortisone—ulcerative colitis	5.27e-05	0.000913	CcSEcCtD
Sulindac—Diarrhoea—Mesalazine—ulcerative colitis	5.24e-05	0.000909	CcSEcCtD
Sulindac—Angioedema—Dexamethasone—ulcerative colitis	5.21e-05	0.000904	CcSEcCtD
Sulindac—Angioedema—Betamethasone—ulcerative colitis	5.21e-05	0.000904	CcSEcCtD
Sulindac—Anorexia—Hydrocortisone—ulcerative colitis	5.19e-05	0.000901	CcSEcCtD
Sulindac—Malaise—Betamethasone—ulcerative colitis	5.14e-05	0.000892	CcSEcCtD
Sulindac—Malaise—Dexamethasone—ulcerative colitis	5.14e-05	0.000892	CcSEcCtD
Sulindac—Anaphylactic shock—Triamcinolone—ulcerative colitis	5.13e-05	0.00089	CcSEcCtD
Sulindac—Oedema—Triamcinolone—ulcerative colitis	5.13e-05	0.00089	CcSEcCtD
Sulindac—Vertigo—Dexamethasone—ulcerative colitis	5.13e-05	0.000889	CcSEcCtD
Sulindac—Vertigo—Betamethasone—ulcerative colitis	5.13e-05	0.000889	CcSEcCtD
Sulindac—Anaphylactic shock—Methylprednisolone—ulcerative colitis	5.12e-05	0.000888	CcSEcCtD
Sulindac—Syncope—Betamethasone—ulcerative colitis	5.12e-05	0.000887	CcSEcCtD
Sulindac—Syncope—Dexamethasone—ulcerative colitis	5.12e-05	0.000887	CcSEcCtD
Sulindac—Arrhythmia—Prednisone—ulcerative colitis	5.1e-05	0.000884	CcSEcCtD
Sulindac—Hypotension—Hydrocortisone—ulcerative colitis	5.09e-05	0.000883	CcSEcCtD
Sulindac—Dizziness—Mesalazine—ulcerative colitis	5.07e-05	0.000879	CcSEcCtD
Sulindac—Shock—Triamcinolone—ulcerative colitis	5.05e-05	0.000875	CcSEcCtD
Sulindac—Insomnia—Prednisolone—ulcerative colitis	5.05e-05	0.000875	CcSEcCtD
Sulindac—Alopecia—Prednisone—ulcerative colitis	5.04e-05	0.000874	CcSEcCtD
Sulindac—Shock—Methylprednisolone—ulcerative colitis	5.04e-05	0.000873	CcSEcCtD
Sulindac—Loss of consciousness—Dexamethasone—ulcerative colitis	5.01e-05	0.000869	CcSEcCtD
Sulindac—Loss of consciousness—Betamethasone—ulcerative colitis	5.01e-05	0.000869	CcSEcCtD
Sulindac—Paraesthesia—Prednisolone—ulcerative colitis	5.01e-05	0.000869	CcSEcCtD
Sulindac—Tachycardia—Triamcinolone—ulcerative colitis	5.01e-05	0.000868	CcSEcCtD
Sulindac—Nausea—Azathioprine—ulcerative colitis	5e-05	0.000866	CcSEcCtD
Sulindac—Tachycardia—Methylprednisolone—ulcerative colitis	5e-05	0.000866	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	4.96e-05	0.000861	CcSEcCtD
Sulindac—Hyperhidrosis—Triamcinolone—ulcerative colitis	4.96e-05	0.00086	CcSEcCtD
Sulindac—Hyperhidrosis—Methylprednisolone—ulcerative colitis	4.95e-05	0.000858	CcSEcCtD
Sulindac—Convulsion—Betamethasone—ulcerative colitis	4.94e-05	0.000857	CcSEcCtD
Sulindac—Convulsion—Dexamethasone—ulcerative colitis	4.94e-05	0.000857	CcSEcCtD
Sulindac—Insomnia—Hydrocortisone—ulcerative colitis	4.93e-05	0.000855	CcSEcCtD
Sulindac—Hypertension—Betamethasone—ulcerative colitis	4.93e-05	0.000854	CcSEcCtD
Sulindac—Hypertension—Dexamethasone—ulcerative colitis	4.93e-05	0.000854	CcSEcCtD
Sulindac—Paraesthesia—Hydrocortisone—ulcerative colitis	4.89e-05	0.000848	CcSEcCtD
Sulindac—Vomiting—Mesalazine—ulcerative colitis	4.87e-05	0.000845	CcSEcCtD
Sulindac—Myalgia—Betamethasone—ulcerative colitis	4.86e-05	0.000842	CcSEcCtD
Sulindac—Myalgia—Dexamethasone—ulcerative colitis	4.86e-05	0.000842	CcSEcCtD
Sulindac—Rash—Mesalazine—ulcerative colitis	4.83e-05	0.000838	CcSEcCtD
Sulindac—Dermatitis—Mesalazine—ulcerative colitis	4.83e-05	0.000837	CcSEcCtD
Sulindac—Headache—Mesalazine—ulcerative colitis	4.8e-05	0.000832	CcSEcCtD
Sulindac—Discomfort—Betamethasone—ulcerative colitis	4.8e-05	0.000832	CcSEcCtD
Sulindac—Discomfort—Dexamethasone—ulcerative colitis	4.8e-05	0.000832	CcSEcCtD
Sulindac—Dyspepsia—Hydrocortisone—ulcerative colitis	4.8e-05	0.000832	CcSEcCtD
Sulindac—Hypotension—Methylprednisolone—ulcerative colitis	4.78e-05	0.000829	CcSEcCtD
Sulindac—Decreased appetite—Hydrocortisone—ulcerative colitis	4.74e-05	0.000821	CcSEcCtD
Sulindac—Fatigue—Hydrocortisone—ulcerative colitis	4.7e-05	0.000815	CcSEcCtD
Sulindac—Vision blurred—Prednisone—ulcerative colitis	4.68e-05	0.000812	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	4.67e-05	0.000811	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	4.66e-05	0.000809	CcSEcCtD
Sulindac—Oedema—Dexamethasone—ulcerative colitis	4.66e-05	0.000807	CcSEcCtD
Sulindac—Oedema—Betamethasone—ulcerative colitis	4.66e-05	0.000807	CcSEcCtD
Sulindac—Anaphylactic shock—Betamethasone—ulcerative colitis	4.66e-05	0.000807	CcSEcCtD
Sulindac—Anaphylactic shock—Dexamethasone—ulcerative colitis	4.66e-05	0.000807	CcSEcCtD
Sulindac—Insomnia—Triamcinolone—ulcerative colitis	4.64e-05	0.000805	CcSEcCtD
Sulindac—Insomnia—Methylprednisolone—ulcerative colitis	4.63e-05	0.000803	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisone—ulcerative colitis	4.61e-05	0.000799	CcSEcCtD
Sulindac—Paraesthesia—Triamcinolone—ulcerative colitis	4.61e-05	0.000799	CcSEcCtD
Sulindac—Feeling abnormal—Prednisolone—ulcerative colitis	4.6e-05	0.000797	CcSEcCtD
Sulindac—Paraesthesia—Methylprednisolone—ulcerative colitis	4.6e-05	0.000797	CcSEcCtD
Sulindac—Anaemia—Prednisone—ulcerative colitis	4.59e-05	0.000796	CcSEcCtD
Sulindac—Shock—Dexamethasone—ulcerative colitis	4.58e-05	0.000794	CcSEcCtD
Sulindac—Shock—Betamethasone—ulcerative colitis	4.58e-05	0.000794	CcSEcCtD
Sulindac—Dyspnoea—Triamcinolone—ulcerative colitis	4.57e-05	0.000793	CcSEcCtD
Sulindac—Thrombocytopenia—Dexamethasone—ulcerative colitis	4.56e-05	0.00079	CcSEcCtD
Sulindac—Thrombocytopenia—Betamethasone—ulcerative colitis	4.56e-05	0.00079	CcSEcCtD
Sulindac—Nausea—Mesalazine—ulcerative colitis	4.55e-05	0.000789	CcSEcCtD
Sulindac—Tachycardia—Betamethasone—ulcerative colitis	4.54e-05	0.000788	CcSEcCtD
Sulindac—Tachycardia—Dexamethasone—ulcerative colitis	4.54e-05	0.000788	CcSEcCtD
Sulindac—Angioedema—Prednisone—ulcerative colitis	4.54e-05	0.000787	CcSEcCtD
Sulindac—Dyspepsia—Triamcinolone—ulcerative colitis	4.52e-05	0.000783	CcSEcCtD
Sulindac—Dyspepsia—Methylprednisolone—ulcerative colitis	4.51e-05	0.000781	CcSEcCtD
Sulindac—Hyperhidrosis—Dexamethasone—ulcerative colitis	4.5e-05	0.00078	CcSEcCtD
Sulindac—Hyperhidrosis—Betamethasone—ulcerative colitis	4.5e-05	0.00078	CcSEcCtD
Sulindac—Feeling abnormal—Hydrocortisone—ulcerative colitis	4.49e-05	0.000779	CcSEcCtD
Sulindac—Malaise—Prednisone—ulcerative colitis	4.48e-05	0.000777	CcSEcCtD
Sulindac—Vertigo—Prednisone—ulcerative colitis	4.46e-05	0.000774	CcSEcCtD
Sulindac—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	4.46e-05	0.000773	CcSEcCtD
Sulindac—Syncope—Prednisone—ulcerative colitis	4.46e-05	0.000772	CcSEcCtD
Sulindac—Anorexia—Dexamethasone—ulcerative colitis	4.44e-05	0.000769	CcSEcCtD
Sulindac—Anorexia—Betamethasone—ulcerative colitis	4.44e-05	0.000769	CcSEcCtD
Sulindac—Urticaria—Prednisolone—ulcerative colitis	4.43e-05	0.000769	CcSEcCtD
Sulindac—Fatigue—Triamcinolone—ulcerative colitis	4.42e-05	0.000767	CcSEcCtD
Sulindac—Fatigue—Methylprednisolone—ulcerative colitis	4.41e-05	0.000765	CcSEcCtD
Sulindac—Loss of consciousness—Prednisone—ulcerative colitis	4.37e-05	0.000757	CcSEcCtD
Sulindac—Hypotension—Dexamethasone—ulcerative colitis	4.35e-05	0.000754	CcSEcCtD
Sulindac—Hypotension—Betamethasone—ulcerative colitis	4.35e-05	0.000754	CcSEcCtD
Sulindac—Urticaria—Hydrocortisone—ulcerative colitis	4.33e-05	0.000751	CcSEcCtD
Sulindac—Body temperature increased—Hydrocortisone—ulcerative colitis	4.31e-05	0.000747	CcSEcCtD
Sulindac—Convulsion—Prednisone—ulcerative colitis	4.3e-05	0.000746	CcSEcCtD
Sulindac—Hypertension—Prednisone—ulcerative colitis	4.29e-05	0.000744	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	4.24e-05	0.000735	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	4.24e-05	0.000735	CcSEcCtD
Sulindac—Myalgia—Prednisone—ulcerative colitis	4.23e-05	0.000733	CcSEcCtD
Sulindac—Arthralgia—Prednisone—ulcerative colitis	4.23e-05	0.000733	CcSEcCtD
Sulindac—Feeling abnormal—Triamcinolone—ulcerative colitis	4.23e-05	0.000733	CcSEcCtD
Sulindac—Feeling abnormal—Methylprednisolone—ulcerative colitis	4.22e-05	0.000732	CcSEcCtD
Sulindac—Insomnia—Dexamethasone—ulcerative colitis	4.21e-05	0.00073	CcSEcCtD
Sulindac—Insomnia—Betamethasone—ulcerative colitis	4.21e-05	0.00073	CcSEcCtD
Sulindac—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	4.19e-05	0.000726	CcSEcCtD
Sulindac—Paraesthesia—Betamethasone—ulcerative colitis	4.18e-05	0.000725	CcSEcCtD
Sulindac—Paraesthesia—Dexamethasone—ulcerative colitis	4.18e-05	0.000725	CcSEcCtD
Sulindac—Discomfort—Prednisone—ulcerative colitis	4.18e-05	0.000725	CcSEcCtD
Sulindac—Hypersensitivity—Prednisolone—ulcerative colitis	4.11e-05	0.000713	CcSEcCtD
Sulindac—Dyspepsia—Dexamethasone—ulcerative colitis	4.1e-05	0.000711	CcSEcCtD
Sulindac—Dyspepsia—Betamethasone—ulcerative colitis	4.1e-05	0.000711	CcSEcCtD
Sulindac—Urticaria—Triamcinolone—ulcerative colitis	4.08e-05	0.000707	CcSEcCtD
Sulindac—Urticaria—Methylprednisolone—ulcerative colitis	4.07e-05	0.000705	CcSEcCtD
Sulindac—Body temperature increased—Triamcinolone—ulcerative colitis	4.06e-05	0.000703	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisone—ulcerative colitis	4.05e-05	0.000703	CcSEcCtD
Sulindac—Oedema—Prednisone—ulcerative colitis	4.05e-05	0.000703	CcSEcCtD
Sulindac—Decreased appetite—Dexamethasone—ulcerative colitis	4.05e-05	0.000702	CcSEcCtD
Sulindac—Decreased appetite—Betamethasone—ulcerative colitis	4.05e-05	0.000702	CcSEcCtD
Sulindac—Hypersensitivity—Hydrocortisone—ulcerative colitis	4.01e-05	0.000696	CcSEcCtD
Sulindac—Fatigue—Dexamethasone—ulcerative colitis	4.01e-05	0.000696	CcSEcCtD
Sulindac—Fatigue—Betamethasone—ulcerative colitis	4.01e-05	0.000696	CcSEcCtD
Sulindac—Shock—Prednisone—ulcerative colitis	3.99e-05	0.000692	CcSEcCtD
Sulindac—Tachycardia—Prednisone—ulcerative colitis	3.96e-05	0.000686	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisone—ulcerative colitis	3.92e-05	0.00068	CcSEcCtD
Sulindac—Asthenia—Hydrocortisone—ulcerative colitis	3.91e-05	0.000678	CcSEcCtD
Sulindac—Anorexia—Prednisone—ulcerative colitis	3.86e-05	0.00067	CcSEcCtD
Sulindac—Pruritus—Hydrocortisone—ulcerative colitis	3.86e-05	0.000668	CcSEcCtD
Sulindac—Feeling abnormal—Dexamethasone—ulcerative colitis	3.84e-05	0.000665	CcSEcCtD
Sulindac—Feeling abnormal—Betamethasone—ulcerative colitis	3.84e-05	0.000665	CcSEcCtD
Sulindac—Gastrointestinal pain—Betamethasone—ulcerative colitis	3.81e-05	0.00066	CcSEcCtD
Sulindac—Gastrointestinal pain—Dexamethasone—ulcerative colitis	3.81e-05	0.00066	CcSEcCtD
Sulindac—Hypersensitivity—Triamcinolone—ulcerative colitis	3.78e-05	0.000655	CcSEcCtD
Sulindac—Hypersensitivity—Methylprednisolone—ulcerative colitis	3.77e-05	0.000654	CcSEcCtD
Sulindac—Diarrhoea—Hydrocortisone—ulcerative colitis	3.73e-05	0.000646	CcSEcCtD
Sulindac—Urticaria—Betamethasone—ulcerative colitis	3.7e-05	0.000641	CcSEcCtD
Sulindac—Urticaria—Dexamethasone—ulcerative colitis	3.7e-05	0.000641	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Prednisone—ulcerative colitis	3.69e-05	0.00064	CcSEcCtD
Sulindac—Dizziness—Prednisolone—ulcerative colitis	3.69e-05	0.00064	CcSEcCtD
Sulindac—Asthenia—Triamcinolone—ulcerative colitis	3.68e-05	0.000638	CcSEcCtD
Sulindac—Body temperature increased—Dexamethasone—ulcerative colitis	3.68e-05	0.000638	CcSEcCtD
Sulindac—Body temperature increased—Betamethasone—ulcerative colitis	3.68e-05	0.000638	CcSEcCtD
Sulindac—Asthenia—Methylprednisolone—ulcerative colitis	3.67e-05	0.000637	CcSEcCtD
Sulindac—Insomnia—Prednisone—ulcerative colitis	3.67e-05	0.000636	CcSEcCtD
Sulindac—Paraesthesia—Prednisone—ulcerative colitis	3.64e-05	0.000631	CcSEcCtD
Sulindac—Pruritus—Triamcinolone—ulcerative colitis	3.63e-05	0.000629	CcSEcCtD
Sulindac—Pruritus—Methylprednisolone—ulcerative colitis	3.62e-05	0.000628	CcSEcCtD
Sulindac—Dizziness—Hydrocortisone—ulcerative colitis	3.6e-05	0.000625	CcSEcCtD
Sulindac—Dyspepsia—Prednisone—ulcerative colitis	3.57e-05	0.000619	CcSEcCtD
Sulindac—Decreased appetite—Prednisone—ulcerative colitis	3.52e-05	0.000611	CcSEcCtD
Sulindac—Rash—Prednisolone—ulcerative colitis	3.52e-05	0.00061	CcSEcCtD
Sulindac—Dermatitis—Prednisolone—ulcerative colitis	3.51e-05	0.000609	CcSEcCtD
Sulindac—Diarrhoea—Methylprednisolone—ulcerative colitis	3.5e-05	0.000607	CcSEcCtD
Sulindac—Fatigue—Prednisone—ulcerative colitis	3.5e-05	0.000606	CcSEcCtD
Sulindac—Headache—Prednisolone—ulcerative colitis	3.5e-05	0.000606	CcSEcCtD
Sulindac—Constipation—Prednisone—ulcerative colitis	3.47e-05	0.000601	CcSEcCtD
Sulindac—Vomiting—Hydrocortisone—ulcerative colitis	3.46e-05	0.000601	CcSEcCtD
Sulindac—Rash—Hydrocortisone—ulcerative colitis	3.44e-05	0.000596	CcSEcCtD
Sulindac—Dermatitis—Hydrocortisone—ulcerative colitis	3.43e-05	0.000595	CcSEcCtD
Sulindac—Headache—Hydrocortisone—ulcerative colitis	3.41e-05	0.000592	CcSEcCtD
Sulindac—Dizziness—Triamcinolone—ulcerative colitis	3.39e-05	0.000588	CcSEcCtD
Sulindac—Dizziness—Methylprednisolone—ulcerative colitis	3.39e-05	0.000587	CcSEcCtD
Sulindac—Feeling abnormal—Prednisone—ulcerative colitis	3.34e-05	0.000579	CcSEcCtD
Sulindac—Asthenia—Betamethasone—ulcerative colitis	3.34e-05	0.000579	CcSEcCtD
Sulindac—Asthenia—Dexamethasone—ulcerative colitis	3.34e-05	0.000579	CcSEcCtD
Sulindac—Gastrointestinal pain—Prednisone—ulcerative colitis	3.32e-05	0.000575	CcSEcCtD
Sulindac—Nausea—Prednisolone—ulcerative colitis	3.31e-05	0.000575	CcSEcCtD
Sulindac—Pruritus—Betamethasone—ulcerative colitis	3.29e-05	0.000571	CcSEcCtD
Sulindac—Pruritus—Dexamethasone—ulcerative colitis	3.29e-05	0.000571	CcSEcCtD
Sulindac—Vomiting—Triamcinolone—ulcerative colitis	3.26e-05	0.000566	CcSEcCtD
Sulindac—Vomiting—Methylprednisolone—ulcerative colitis	3.26e-05	0.000564	CcSEcCtD
Sulindac—Nausea—Hydrocortisone—ulcerative colitis	3.24e-05	0.000561	CcSEcCtD
Sulindac—Rash—Triamcinolone—ulcerative colitis	3.24e-05	0.000561	CcSEcCtD
Sulindac—Dermatitis—Triamcinolone—ulcerative colitis	3.23e-05	0.00056	CcSEcCtD
Sulindac—Rash—Methylprednisolone—ulcerative colitis	3.23e-05	0.00056	CcSEcCtD
Sulindac—Dermatitis—Methylprednisolone—ulcerative colitis	3.23e-05	0.000559	CcSEcCtD
Sulindac—Urticaria—Prednisone—ulcerative colitis	3.22e-05	0.000558	CcSEcCtD
Sulindac—Headache—Triamcinolone—ulcerative colitis	3.21e-05	0.000557	CcSEcCtD
Sulindac—Headache—Methylprednisolone—ulcerative colitis	3.21e-05	0.000556	CcSEcCtD
Sulindac—Body temperature increased—Prednisone—ulcerative colitis	3.21e-05	0.000556	CcSEcCtD
Sulindac—Diarrhoea—Dexamethasone—ulcerative colitis	3.19e-05	0.000552	CcSEcCtD
Sulindac—Diarrhoea—Betamethasone—ulcerative colitis	3.19e-05	0.000552	CcSEcCtD
Sulindac—Dizziness—Dexamethasone—ulcerative colitis	3.08e-05	0.000534	CcSEcCtD
Sulindac—Dizziness—Betamethasone—ulcerative colitis	3.08e-05	0.000534	CcSEcCtD
Sulindac—Nausea—Triamcinolone—ulcerative colitis	3.05e-05	0.000528	CcSEcCtD
Sulindac—Nausea—Methylprednisolone—ulcerative colitis	3.04e-05	0.000527	CcSEcCtD
Sulindac—Hypersensitivity—Prednisone—ulcerative colitis	2.99e-05	0.000518	CcSEcCtD
Sulindac—Vomiting—Betamethasone—ulcerative colitis	2.96e-05	0.000513	CcSEcCtD
Sulindac—Vomiting—Dexamethasone—ulcerative colitis	2.96e-05	0.000513	CcSEcCtD
Sulindac—Rash—Dexamethasone—ulcerative colitis	2.94e-05	0.000509	CcSEcCtD
Sulindac—Rash—Betamethasone—ulcerative colitis	2.94e-05	0.000509	CcSEcCtD
Sulindac—Dermatitis—Dexamethasone—ulcerative colitis	2.93e-05	0.000509	CcSEcCtD
Sulindac—Dermatitis—Betamethasone—ulcerative colitis	2.93e-05	0.000509	CcSEcCtD
Sulindac—Headache—Dexamethasone—ulcerative colitis	2.92e-05	0.000506	CcSEcCtD
Sulindac—Headache—Betamethasone—ulcerative colitis	2.92e-05	0.000506	CcSEcCtD
Sulindac—Asthenia—Prednisone—ulcerative colitis	2.91e-05	0.000504	CcSEcCtD
Sulindac—Pruritus—Prednisone—ulcerative colitis	2.87e-05	0.000497	CcSEcCtD
Sulindac—Diarrhoea—Prednisone—ulcerative colitis	2.77e-05	0.000481	CcSEcCtD
Sulindac—Nausea—Betamethasone—ulcerative colitis	2.77e-05	0.000479	CcSEcCtD
Sulindac—Nausea—Dexamethasone—ulcerative colitis	2.77e-05	0.000479	CcSEcCtD
Sulindac—Dizziness—Prednisone—ulcerative colitis	2.68e-05	0.000465	CcSEcCtD
Sulindac—Vomiting—Prednisone—ulcerative colitis	2.58e-05	0.000447	CcSEcCtD
Sulindac—Rash—Prednisone—ulcerative colitis	2.56e-05	0.000443	CcSEcCtD
Sulindac—Dermatitis—Prednisone—ulcerative colitis	2.55e-05	0.000443	CcSEcCtD
Sulindac—Headache—Prednisone—ulcerative colitis	2.54e-05	0.00044	CcSEcCtD
Sulindac—Nausea—Prednisone—ulcerative colitis	2.41e-05	0.000418	CcSEcCtD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.34e-05	0.000206	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	1.34e-05	0.000206	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC11A1—ulcerative colitis	1.33e-05	0.000205	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ADCY5—ulcerative colitis	1.33e-05	0.000205	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	1.33e-05	0.000205	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	1.33e-05	0.000204	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—HNF4A—ulcerative colitis	1.32e-05	0.000204	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—TGFB1—ulcerative colitis	1.32e-05	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PTGER4—ulcerative colitis	1.32e-05	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—JAK2—ulcerative colitis	1.32e-05	0.000202	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—IL6—ulcerative colitis	1.31e-05	0.000202	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—IL6—ulcerative colitis	1.31e-05	0.000202	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—MMP1—ulcerative colitis	1.31e-05	0.000201	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CHP1—ulcerative colitis	1.31e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FCGR2A—ulcerative colitis	1.31e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	1.3e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL2—ulcerative colitis	1.29e-05	0.000198	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MAML2—ulcerative colitis	1.29e-05	0.000198	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.28e-05	0.000196	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.27e-05	0.000195	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—ulcerative colitis	1.27e-05	0.000195	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—NFKB1—ulcerative colitis	1.27e-05	0.000195	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ABCB1—ulcerative colitis	1.26e-05	0.000193	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	1.26e-05	0.000193	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—IL6—ulcerative colitis	1.26e-05	0.000193	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PTPN2—ulcerative colitis	1.25e-05	0.000192	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—ulcerative colitis	1.25e-05	0.000192	CbGpPWpGaD
Sulindac—PTGS2—Disease—SEL1L—ulcerative colitis	1.24e-05	0.000191	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—IL6—ulcerative colitis	1.24e-05	0.00019	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.23e-05	0.000188	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	1.22e-05	0.000187	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—NFKB1—ulcerative colitis	1.21e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—GHRL—ulcerative colitis	1.21e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCR1—ulcerative colitis	1.2e-05	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Disease—MAML2—ulcerative colitis	1.2e-05	0.000184	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	1.2e-05	0.000184	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—NFKB1—ulcerative colitis	1.19e-05	0.000183	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.18e-05	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—ulcerative colitis	1.18e-05	0.000182	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—ulcerative colitis	1.18e-05	0.000181	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ADCY5—ulcerative colitis	1.17e-05	0.000181	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CALM3—ulcerative colitis	1.17e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—ulcerative colitis	1.17e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CRP—ulcerative colitis	1.16e-05	0.000179	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—ulcerative colitis	1.16e-05	0.000179	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CHP1—ulcerative colitis	1.16e-05	0.000178	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—ulcerative colitis	1.16e-05	0.000178	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—ulcerative colitis	1.15e-05	0.000177	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	1.15e-05	0.000176	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	1.14e-05	0.000176	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	1.14e-05	0.000175	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—STAT3—ulcerative colitis	1.14e-05	0.000175	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—DLD—ulcerative colitis	1.13e-05	0.000174	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—PPARG—ulcerative colitis	1.13e-05	0.000173	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.13e-05	0.000173	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—PPARG—ulcerative colitis	1.12e-05	0.000173	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TLR4—ulcerative colitis	1.12e-05	0.000172	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	1.12e-05	0.000172	CbGpPWpGaD
Sulindac—PTGS2—Disease—LTF—ulcerative colitis	1.11e-05	0.000171	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—ulcerative colitis	1.1e-05	0.000168	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—ulcerative colitis	1.1e-05	0.000168	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	1.1e-05	0.000168	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—JAK2—ulcerative colitis	1.09e-05	0.000167	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.09e-05	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—MMP9—ulcerative colitis	1.09e-05	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	1.09e-05	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—ulcerative colitis	1.09e-05	0.000167	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—ulcerative colitis	1.08e-05	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—ulcerative colitis	1.07e-05	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CALM3—ulcerative colitis	1.07e-05	0.000164	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—STAT3—ulcerative colitis	1.07e-05	0.000164	CbGpPWpGaD
Sulindac—ALB—Metabolism—CHP1—ulcerative colitis	1.06e-05	0.000163	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL20—ulcerative colitis	1.06e-05	0.000162	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RELA—ulcerative colitis	1.05e-05	0.000162	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RIPK2—ulcerative colitis	1.05e-05	0.000162	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—ulcerative colitis	1.05e-05	0.000162	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTLA4—ulcerative colitis	1.04e-05	0.00016	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—DLD—ulcerative colitis	1e-05	0.000154	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ADRB2—ulcerative colitis	1e-05	0.000154	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCL8—ulcerative colitis	9.94e-06	0.000153	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GNA12—ulcerative colitis	9.93e-06	0.000153	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—ALB—ulcerative colitis	9.92e-06	0.000152	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.92e-06	0.000152	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—ulcerative colitis	9.9e-06	0.000152	CbGpPWpGaD
Sulindac—MAPK3—Disease—CALM3—ulcerative colitis	9.87e-06	0.000152	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	9.84e-06	0.000151	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CALM3—ulcerative colitis	9.81e-06	0.000151	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	9.76e-06	0.00015	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	9.7e-06	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NOD2—ulcerative colitis	9.55e-06	0.000147	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—ulcerative colitis	9.5e-06	0.000146	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD14—ulcerative colitis	9.49e-06	0.000146	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—ulcerative colitis	9.45e-06	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCR2—ulcerative colitis	9.42e-06	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—JAK2—ulcerative colitis	9.4e-06	0.000144	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	9.37e-06	0.000144	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—JAK2—ulcerative colitis	9.22e-06	0.000142	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	9.22e-06	0.000142	CbGpPWpGaD
Sulindac—MAPK3—Immune System—VCAM1—ulcerative colitis	9.16e-06	0.000141	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQA1—ulcerative colitis	9.14e-06	0.00014	CbGpPWpGaD
Sulindac—ALB—Metabolism—DLD—ulcerative colitis	9.14e-06	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—RELA—ulcerative colitis	9.1e-06	0.00014	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	9.01e-06	0.000138	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MMP9—ulcerative colitis	8.99e-06	0.000138	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NFKB1—ulcerative colitis	8.9e-06	0.000137	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR6—ulcerative colitis	8.85e-06	0.000136	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PPARG—ulcerative colitis	8.76e-06	0.000135	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—ulcerative colitis	8.69e-06	0.000134	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	8.61e-06	0.000132	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—ADCY5—ulcerative colitis	8.49e-06	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAML2—ulcerative colitis	8.39e-06	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—JAK2—ulcerative colitis	8.3e-06	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—VDR—ulcerative colitis	8.25e-06	0.000127	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	8.13e-06	0.000125	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—ulcerative colitis	8.04e-06	0.000124	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—RELA—ulcerative colitis	8.04e-06	0.000124	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—STAT3—ulcerative colitis	7.99e-06	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—ulcerative colitis	7.95e-06	0.000122	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	7.95e-06	0.000122	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC11A1—ulcerative colitis	7.93e-06	0.000122	CbGpPWpGaD
Sulindac—PPARD—Metabolism—ALB—ulcerative colitis	7.88e-06	0.000121	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—ulcerative colitis	7.87e-06	0.000121	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTGER4—ulcerative colitis	7.79e-06	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—MMP9—ulcerative colitis	7.76e-06	0.000119	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ADCY5—ulcerative colitis	7.75e-06	0.000119	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NFKB1—ulcerative colitis	7.68e-06	0.000118	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	7.59e-06	0.000117	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—ulcerative colitis	7.59e-06	0.000117	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.52e-06	0.000116	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	7.51e-06	0.000115	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—ulcerative colitis	7.46e-06	0.000115	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TGFB1—ulcerative colitis	7.41e-06	0.000114	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CHP1—ulcerative colitis	7.4e-06	0.000114	CbGpPWpGaD
Sulindac—MAPK3—Disease—ADCY5—ulcerative colitis	7.16e-06	0.00011	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GHRL—ulcerative colitis	7.14e-06	0.00011	CbGpPWpGaD
Sulindac—PTGS2—Disease—MAML2—ulcerative colitis	7.13e-06	0.00011	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	6.94e-06	0.000107	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CALM3—ulcerative colitis	6.91e-06	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—STAT3—ulcerative colitis	6.9e-06	0.000106	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGS2—ulcerative colitis	6.89e-06	0.000106	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RIPK2—ulcerative colitis	6.81e-06	0.000105	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CRP—ulcerative colitis	6.78e-06	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NFKB1—ulcerative colitis	6.78e-06	0.000104	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.76e-06	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—ulcerative colitis	6.75e-06	0.000104	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	6.7e-06	0.000103	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	6.6e-06	0.000101	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR4—ulcerative colitis	6.5e-06	0.0001	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DRB1—ulcerative colitis	6.5e-06	9.99e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—ulcerative colitis	6.39e-06	9.83e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—DLD—ulcerative colitis	6.39e-06	9.82e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—MMP1—ulcerative colitis	6.3e-06	9.68e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—ulcerative colitis	6.27e-06	9.64e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ICAM1—ulcerative colitis	6.24e-06	9.59e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CALM3—ulcerative colitis	6.19e-06	9.52e-05	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.16e-06	9.47e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—ulcerative colitis	6.1e-06	9.38e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.97e-06	9.18e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—ulcerative colitis	5.97e-06	9.18e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.92e-06	9.1e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADRB2—ulcerative colitis	5.91e-06	9.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CALM3—ulcerative colitis	5.87e-06	9.02e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	5.86e-06	9e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARG—ulcerative colitis	5.75e-06	8.84e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—ulcerative colitis	5.58e-06	8.58e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CDH1—ulcerative colitis	5.51e-06	8.48e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PTGS1—ulcerative colitis	5.46e-06	8.39e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.37e-06	8.25e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.3e-06	8.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—JAK2—ulcerative colitis	5.29e-06	8.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—ulcerative colitis	5.16e-06	7.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADCY5—ulcerative colitis	5.01e-06	7.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CALM3—ulcerative colitis	4.92e-06	7.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—ulcerative colitis	4.87e-06	7.49e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS1—ulcerative colitis	4.84e-06	7.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—JAK2—ulcerative colitis	4.83e-06	7.43e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.83e-06	7.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—ulcerative colitis	4.83e-06	7.42e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—ulcerative colitis	4.82e-06	7.41e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ABCB1—ulcerative colitis	4.81e-06	7.4e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.77e-06	7.32e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—ulcerative colitis	4.75e-06	7.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RELA—ulcerative colitis	4.68e-06	7.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—ulcerative colitis	4.62e-06	7.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—ulcerative colitis	4.58e-06	7.04e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ADCY5—ulcerative colitis	4.49e-06	6.9e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—JAK2—ulcerative colitis	4.46e-06	6.86e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—JAK2—ulcerative colitis	4.44e-06	6.82e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS1—ulcerative colitis	4.42e-06	6.79e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CALM3—ulcerative colitis	4.36e-06	6.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ADCY5—ulcerative colitis	4.26e-06	6.54e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—ulcerative colitis	4.26e-06	6.54e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—ulcerative colitis	4.23e-06	6.51e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—ulcerative colitis	4.23e-06	6.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—ulcerative colitis	4.22e-06	6.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—ulcerative colitis	4.2e-06	6.46e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.17e-06	6.41e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CALM3—ulcerative colitis	3.98e-06	6.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NFKB1—ulcerative colitis	3.95e-06	6.07e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—ulcerative colitis	3.87e-06	5.95e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ABCB1—ulcerative colitis	3.82e-06	5.88e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.8e-06	5.84e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ADCY5—ulcerative colitis	3.57e-06	5.48e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—ulcerative colitis	3.55e-06	5.45e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCB1—ulcerative colitis	3.39e-06	5.21e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.38e-06	5.19e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—ulcerative colitis	3.35e-06	5.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—ulcerative colitis	3.28e-06	5.04e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ADCY5—ulcerative colitis	3.16e-06	4.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—JAK2—ulcerative colitis	3.13e-06	4.8e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCB1—ulcerative colitis	3.09e-06	4.75e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS1—ulcerative colitis	3.09e-06	4.75e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.04e-06	4.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—ulcerative colitis	3.04e-06	4.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RELA—ulcerative colitis	3.03e-06	4.65e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—ulcerative colitis	3.02e-06	4.64e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ALB—ulcerative colitis	3.01e-06	4.63e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ADCY5—ulcerative colitis	2.88e-06	4.43e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—ulcerative colitis	2.85e-06	4.38e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CALM3—ulcerative colitis	2.78e-06	4.28e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—ulcerative colitis	2.73e-06	4.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—ulcerative colitis	2.71e-06	4.17e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—ulcerative colitis	2.66e-06	4.09e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.66e-06	4.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—JAK2—ulcerative colitis	2.65e-06	4.08e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—ulcerative colitis	2.64e-06	4.05e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MMP9—ulcerative colitis	2.58e-06	3.97e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NFKB1—ulcerative colitis	2.55e-06	3.92e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—ulcerative colitis	2.52e-06	3.87e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—ulcerative colitis	2.48e-06	3.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—ulcerative colitis	2.48e-06	3.81e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ALB—ulcerative colitis	2.39e-06	3.68e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—ulcerative colitis	2.36e-06	3.63e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—ulcerative colitis	2.29e-06	3.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—ulcerative colitis	2.29e-06	3.52e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCB1—ulcerative colitis	2.16e-06	3.32e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—ulcerative colitis	2.15e-06	3.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—ulcerative colitis	2.13e-06	3.27e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ALB—ulcerative colitis	2.12e-06	3.26e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ADCY5—ulcerative colitis	2.02e-06	3.1e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—ulcerative colitis	1.95e-06	2.99e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—ulcerative colitis	1.86e-06	2.85e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—ulcerative colitis	1.81e-06	2.78e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—ulcerative colitis	1.75e-06	2.69e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—ulcerative colitis	1.69e-06	2.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—ulcerative colitis	1.6e-06	2.46e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—ulcerative colitis	1.5e-06	2.31e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—ulcerative colitis	1.36e-06	2.09e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ALB—ulcerative colitis	1.35e-06	2.08e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.18e-06	1.82e-05	CbGpPWpGaD
